Volume 120, Issue 4, Pages (March 2001)

Slides:



Advertisements
Similar presentations
Volume 115, Issue 4, Pages (October 1998)
Advertisements

Volume 124, Issue 5, Pages (May 2003)
Volume 136, Issue 1, Pages (January 2009)
Volume 40, Issue 4, Pages (April 2014)
Volume 119, Issue 1, Pages (July 2000)
Volume 25, Issue 2, Pages (August 2006)
Volume 140, Issue 1, Pages e2 (January 2011)
Volume 133, Issue 4, Pages (October 2007)
Volume 143, Issue 5, Pages (November 2012)
Exacerbated colitis associated with elevated levels of activated CD4+ T cells in TCRα chain transgenic mice  Immo Prinz, Uwe Klemm, Stefan H.E. Kaufmann,
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 119, Issue 1, Pages (July 2000)
Volume 129, Issue 1, Pages (July 2005)
Volume 130, Issue 2, Pages (February 2006)
Volume 133, Issue 1, Pages (July 2007)
Volume 124, Issue 5, Pages (May 2003)
Volume 122, Issue 1, Pages (January 2002)
Volume 42, Issue 5, Pages (May 2015)
Volume 142, Issue 2, Pages e2 (February 2012)
Galectin-1 suppresses experimental colitis in mice
Volume 30, Issue 3, Pages (March 2009)
Volume 132, Issue 7, Pages (June 2007)
Volume 18, Issue 5, Pages (May 2003)
Volume 128, Issue 5, Pages (May 2005)
Volume 140, Issue 7, Pages (June 2011)
Role of Toll-like Receptors in Spontaneous Commensal-Dependent Colitis
Volume 28, Issue 4, Pages (April 2008)
Volume 134, Issue 4, Pages e2 (April 2008)
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 132, Issue 5, Pages (May 2007)
Volume 143, Issue 1, Pages (July 2012)
Volume 141, Issue 5, Pages e2 (November 2011)
Volume 131, Issue 5, Pages (November 2006)
Volume 138, Issue 2, Pages (February 2010)
Volume 7, Issue 2, Pages (February 2010)
Volume 125, Issue 6, Pages (December 2003)
Volume 132, Issue 1, Pages (January 2007)
Rapid development of colitis in NSAID-treated IL-10–deficient mice
Volume 128, Issue 3, Pages (March 2005)
Volume 29, Issue 6, Pages (December 2008)
Volume 40, Issue 4, Pages (April 2014)
Sarah R. Guehler, Jeffrey A. Bluestone, Terrence A. Barrett 
Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased states  Grzegorz W. Telega, *,‡, Daniel C. Baumgart,
Volume 129, Issue 3, Pages (September 2005)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 33, Issue 5, Pages (November 2010)
Volume 135, Issue 5, Pages e5 (November 2008)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques  Joseph J. Mattapallil, Satya.
Volume 122, Issue 7, Pages (June 2002)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen- Specific Regulatory T Cells  Dan Blat, Ehud Zigmond, Zoya Alteber,
Volume 128, Issue 4, Pages (April 2005)
Volume 118, Issue 5, Pages (May 2000)
Leptin: A pivotal mediator of intestinal inflammation in mice
Volume 121, Issue 6, Pages (December 2001)
Volume 16, Issue 2, Pages (February 2002)
Volume 119, Issue 3, Pages (September 2000)
Volume 119, Issue 1, Pages (July 2000)
Volume 123, Issue 6, Pages (December 2002)
Staphylococcal enterotoxin A–activated regulatory T cells promote allergen-specific TH2 response to intratracheal allergen inoculation  Wei-ping Zeng,
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 131, Issue 2, Pages (August 2006)
Volume 34, Issue 3, Pages (March 2011)
Volume 136, Issue 7, Pages (June 2009)
Volume 131, Issue 6, Pages (December 2006)
Volume 127, Issue 3, Pages (September 2004)
Volume 25, Issue 4, Pages (April 2017)
Volume 25, Issue 3, Pages (September 2006)
Presentation transcript:

Volume 120, Issue 4, Pages 900-913 (March 2001) Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tgϵ26 mice  Claudia Veltkamp, Susan L. Tonkonogy, Ype P. de Jong, Carol Albright, Wetonia B. Grenther, Edward Balish, Cox Terhorst, R.Balfour Sartor  Gastroenterology  Volume 120, Issue 4, Pages 900-913 (March 2001) DOI: 10.1053/gast.2001.22547 Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 1 Photomicrographs of the colons of SPF and GF Tgϵ26 mice after BM transplant or MLN cell transfer. Representative H&E-stained sections from the distal colon are shown (original magnification 66×). (A) Normal colon from a nontransplanted SPF Tgϵ26 mouse. (B) Moderate colitis in a SPF Tgϵ26 mouse 5 weeks after BM transplantation showing crypt hyperplasia, decreased goblet cells, and pronounced lamina propria lymphocytic infiltration. (C) Normal colon from a nontransplanted GF Tgϵ26 mouse. (D) No signs of colonic inflammation are seen in a BM⇒GF Tgϵ26 recipient 12 weeks after transplantation. (E) Severe colitis in an SPF Tgϵ26 mouse injected 2 weeks previously with MLN cells from a BM⇒SPF Tgϵ26 mouse with colitis. Extensive lamina propria cellular infiltration, crypt hyperplasia, and crypt abscesses are evident. (F) No signs of inflammation are seen in the colon of a GF Tgϵ26 mouse 8 weeks after transfer of the same source of MLN cells used in the SPF mouse shown in E. (G) Severe cecal inflammation in a BM⇒GF Tgϵ26 animal maintained in a GF environment for 8 weeks and then colonized with SPF intestinal bacteria for 4 weeks. (H) Active colitis in an SPF Tgϵ26 recipient 3 weeks after transfer of MLN cells obtained from a BM⇒GF Tgϵ26 mouse free of colitis 8 weeks after transplantation. Gastroenterology 2001 120, 900-913DOI: (10.1053/gast.2001.22547) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 2 (A) Blinded histologic score and (B) IL-12 (p40) secretion detected in supernatants of cultured fragments of the colon of BM⇒Tgϵ26 mice in the presence and absence of SPF bacteria. GF or SPF Tgϵ26 recipients were transplanted with BM from normal mice (n = 24 in both groups) and killed 4–6 weeks (SPF) or 8, 12, or 24 weeks (GF) later. Inflammation was scored on a scale of 0–4 (see Materials and Methods), and results are expressed as means ± SEM. Supernatants were collected after 18 hours of culture, and IL-12 (p40) was detected by ELISA. *P < 0.0001 vs. GF mice. Gastroenterology 2001 120, 900-913DOI: (10.1053/gast.2001.22547) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 3 Cytokine production detected in supernatants of MLN cell cultures 3 days after stimulation with anti-CD3 antibody. (A) IFN-γ and (B) IL-4 were measured by ELISA. Values represent means ± SEM nanograms per milliliter (IFN-γ) or picograms per milliliter (IL-4) in supernatants of MLN cell cultures from SPF (n = 17) and GF (n = 16) Tgϵ26 mice after BM transplantation and from SPF normal mice (n = 18). Limits of detection are 5 pg/mL of IFN-γ and 1 pg/mL of IL-4. *P < 0.05 vs. GF Tgϵ26 and vs. normal mice; **P < 0.05 vs. SPF Tgϵ26 and normal mice. Gastroenterology 2001 120, 900-913DOI: (10.1053/gast.2001.22547) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 4 Intracytoplasmic staining of (A and C) IFN-γ and (B and D) TNF. Dot plots for gated CD4+ MLN cells of representative GF and SPF Tgϵ26 mice after BM transplantation or an SPF control mouse analyzed by flow cytometry after overnight stimulation with immobilized anti-CD3 antibody. The summation of intracytoplasmic staining of (C) IFN-γ and (D) TNF is shown in gated CD4+ MLN cells from GF (n = 5) and SPF (n = 6) Tgϵ26 mice after BM transplantation and from normal mice (n = 3). The mean percentages ± SEM of cytokine-positive cells are shown. (C) *P < 0.01 vs. GF and vs. normal mice; **P < 0.001 vs. normal mice. (D) *P < 0.001 vs. GF and vs. normal mice. Gastroenterology 2001 120, 900-913DOI: (10.1053/gast.2001.22547) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 5 IFN-γ production by CD4+ T cells stimulated with APCs pulsed overnight with cecal extracts from SPF or GF Tgϵ26 mice, epithelial cells from GF Tgϵ26 mice, KLH, or no antigen. Supernatants collected on day 3 of culture were assayed for IFN-γ by ELISA. Values represent means ± SD of units per milliliter of IFN-γ in supernatants of pooled CD4+ MLN cells from 3 BM⇒SPF Tgϵ26 mice with colitis in duplicate or triplicate cultures. *P < 0.005 vs. all other groups. Gastroenterology 2001 120, 900-913DOI: (10.1053/gast.2001.22547) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 6 (A) Blinded colonic histologic scores and (B) IL-12 (p40) secreted from cultured fragments of the colons of GF or SPF Tgϵ26 recipients that received MLN cells obtained from BM⇒SPF Tgϵ26 mice with colitis (n = 12, SPF group; n = 5, GF group) and were killed 2–4 weeks (SPF) or 8 weeks (GF) later. Histologic scores and IL-12 measurements were performed as described in Figure 2 and expressed as means ± SEM. *P < 0.001 vs. GF mice. Gastroenterology 2001 120, 900-913DOI: (10.1053/gast.2001.22547) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 7 Comparison of infiltrating CD4+ T lymphocytes in the colonic mucosa of (A) GF and (B) SPF Tgϵ26 mice, both reconstituted with MLN cells from BM⇒SPF Tgϵ26 mice with colitis (original magnification 66×). CD4+ cells were identified by immunohistochemistry using the AEC substrate shown in brown, counterstained with H&E. Gastroenterology 2001 120, 900-913DOI: (10.1053/gast.2001.22547) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 8 Flow-cytometric analysis of the expression of activation/memory markers in CD4+ MLN cells in SPF and GF Tgϵ26 mice after MLN cell transfer from BM⇒SPF Tgϵ26 mice with colitis and in normal mice. (A) Dot plots showing representative proportions of CD4+ and CD8+ MLN cells in SPF and GF recipient Tgϵ26 mice after MLN cell transfer from SPF Tgϵ26 mice with colitis and proportions of CD4+ and CD8+ MLN cells in normal mice (top row). Representative histograms are shown for the expression of L-selectin, CD44, CD45RB, and CD69 on gated CD4+ MLN cells. (B) The percentages of CD4+ cells that are L-selectinneg, CD44hi, CD45RBlo, and CD69pos were determined for MLN cells from SPF (n = 6) or GF (n = 5) Tgϵ26 mice after MLN cell transfer from BM⇒SPF Tgϵ26 mice with colitis or from normal mice (n = 11). Data are the mean values ± SEM calculated for each group. *P < 0.0001 vs. normal mice; **P < 0.01 vs. normal mice. Gastroenterology 2001 120, 900-913DOI: (10.1053/gast.2001.22547) Copyright © 2001 American Gastroenterological Association Terms and Conditions